Guillain-Barré Syndrome (GBS) is a rare neuromuscular condition that can cause rapid paralysis. Diagnosing GBS is challenging, and misdiagnosis can lead to delayed treatment and potentially long-term ...
Please provide your email address to receive an email when new articles are posted on . Results from a phase 2 clinical trial showed that treatment with an IgG-cleaving enzyme for individuals ...
Annexon, Inc. (NASDAQ:ANNX) on Tuesday presented data for its late-stage targeted therapy, tanruprubart (formerly ANX005), for Guillain-Barré Syndrome (GBS). GBS is a neuromuscular emergency affecting ...
MONTREAL — An investigational targeted immunotherapy for Guillain-Barré syndrome (GBS) more than doubled improvement in disability after 8 weeks compared with placebo and showed sustained benefit at ...
VIRGINIA BEACH, Va. — A Virginia Beach man collapsed at home, was paralyzed and put on life support after contracting a rare neurological disorder that nearly killed him. Now Ra-Jon James is walking ...
Ali Sudderth, a 33-year-old woman said that she woke up with "tingly" toes and slowly her entire body became numb and she ...